Statin-induced lung diseases

Kristina Lalić (Zagreb, Croatia), Kristina Lalic, Jasna Tekavec Trkanjec, Marija Šimic, Neven Tudoric

Source: International Congress 2016 – Sarcoidosis
Session: Sarcoidosis
Session type: Thematic Poster
Number: 834
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kristina Lalić (Zagreb, Croatia), Kristina Lalic, Jasna Tekavec Trkanjec, Marija Šimic, Neven Tudoric. Statin-induced lung diseases. Eur Respir J 2016; 48: Suppl. 60, 834

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors predicting resolution in nitrofurantoin-induced lung disease
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Imaging of interstitial lung diseases
Source: International Congress 2019 – PG7 Chest radiology
Year: 2019


Interstitial lung diseases
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013


Interstitial lung diseases
Source: Eur Respir Monogr 2014; 65: 79-87
Year: 2014


Interstitial lung diseases
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Interstitial lung diseases
Source: ERS Course 2015
Year: 2015

Interstitial lung diseases
Source: Eur Respir Monogr 2015; 70: 99-115
Year: 2015


Interstitial lung diseases
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

Interstitial lung diseases
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012

Markers of injury and fibrosis in occupational interstitial lung diseases (OILD)
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Clues in interstitial lung disease in children (chILD)
Source: International Congress 2016 – Paediatric bronchology II
Year: 2016

Characterization of emphysema in active farmer’s lung disease
Source: International Congress 2016 – Occupational epidemiology
Year: 2016

Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014


HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Diffuse pulmonary ossification
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


OSA with intertitial lung diseases
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016